BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11687017)

  • 61. Opportunities to Prevent Alcoholic Liver Cirrhosis in High-Risk Populations: A Systematic Review With Meta-Analysis.
    Askgaard G; Kjær MS; Tolstrup JS
    Am J Gastroenterol; 2019 Feb; 114(2):221-232. PubMed ID: 30353053
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Colchicine treatment of cirrhosis: answers.
    Kershenobich D; Vargas F; Garcia-Tsao G; Tamayo RP; Gent M; Rojkind M
    Hepatology; 1989 Apr; 9(4):656-7. PubMed ID: 2925170
    [No Abstract]   [Full Text] [Related]  

  • 63. Colchicine treatment of cirrhosis: questions.
    Grace ND
    Hepatology; 1989 Apr; 9(4):655-6. PubMed ID: 2925169
    [No Abstract]   [Full Text] [Related]  

  • 64. Review article: the treatment of alcoholic liver disease.
    Blendis LM
    Aliment Pharmacol Ther; 1992 Oct; 6(5):541-8. PubMed ID: 1420746
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Studies on cirrhosis of the liver. IV. The relations between the mortality from liver cirrhosis and the mortality from alcoholism, and between the mortality from liver cirrhosis and alcoholic consumption.
    NAKAMURA T; NAKAMURA S; KAWAMURA E; KANEKO T; SUGAWARA K; KATAKURA Y; ISONO T; SUZUKI I
    Tohoku J Exp Med; 1958 Apr; 67(4):365-71. PubMed ID: 13581054
    [No Abstract]   [Full Text] [Related]  

  • 66. "Alcoholic," "unspecified" and "other specified" cirrhosis mortality: a study in validity.
    Hyman MM
    J Stud Alcohol; 1981 Mar; 42(3):336-43. PubMed ID: 7278277
    [No Abstract]   [Full Text] [Related]  

  • 67. Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment.
    Meikle PJ; Mundra PA; Wong G; Rahman K; Huynh K; Barlow CK; Duly AM; Haber PS; Whitfield JB; Seth D
    PLoS One; 2015; 10(6):e0130346. PubMed ID: 26107182
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of hepatic fibrogenesis: a review of pharmacologic candidates.
    Wu J; Danielsson A
    Scand J Gastroenterol; 1994 May; 29(5):385-91. PubMed ID: 8036452
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical trials of penicillamine in Indian childhood cirrhosis.
    Tanner MS; Bhave SA; Pradhan AM; Pandit AN
    Arch Dis Child; 1987 Nov; 62(11):1118-24. PubMed ID: 3318711
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?
    Hagström H
    Curr Hepatol Rep; 2017; 16(2):152-157. PubMed ID: 28706775
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correlation Analysis of IL-17, IL-21, IL-23 with Non-Alcoholic Liver Fibrosis and Cirrhosis.
    Yang X; Liao L; Liang Z; Yu S; Guo Z
    J Inflamm Res; 2024; 17():2327-2335. PubMed ID: 38651006
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of primary biliary cirrhosis.
    Babbs C; Smith A; Warnes TW
    Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1486-7. PubMed ID: 3121074
    [No Abstract]   [Full Text] [Related]  

  • 73. LIVER CIRRHOSIS WITH CRYPTOGENIC GENESES. CLINICAL CASE.
    Horlenko OM; Kossey GB; Pushkarenko OA; Prylypko LB
    Wiad Lek; 2022; 75(10):2536-2540. PubMed ID: 36472294
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pork and cirrhosis.
    McConway KJ
    Lancet; 1985 May; 1(8436):1045-6. PubMed ID: 2859494
    [No Abstract]   [Full Text] [Related]  

  • 75. Pathogenesis and management of alcoholic liver cirrhosis: a review.
    Huang YW; Yang SS; Kao JH
    Hepat Med; 2011 Dec; 3():1-11. PubMed ID: 24367215
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mortality and drug exposure in a 5-year cohort of patients with chronic liver disease.
    Hug BL; Lipsitz SR; Seger DL; Karson AS; Wright SC; Bates DW
    Swiss Med Wkly; 2009 Dec; 139(51-52):737-46. PubMed ID: 19924579
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Managing medicines in alcohol-associated liver disease: a practical review.
    Johnson AL; Hayward KL
    Aust Prescr; 2021 Jun; 44(3):96-106. PubMed ID: 34211248
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Testing beneficial therapy in human cirrhosis using animal models of cirrhosis.
    Hoefs JC; Morgan T; Ilagan BJ
    Dig Dis Sci; 2011 Apr; 56(4):929-30. PubMed ID: 21365242
    [No Abstract]   [Full Text] [Related]  

  • 79. Antihepatic Fibrosis Drugs in Clinical Trials.
    Guo YC; Lu LG
    J Clin Transl Hepatol; 2020 Sep; 8(3):304-312. PubMed ID: 33083254
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alcohol and cirrhosis.
    Myddelton G
    Br Med J; 1978 Mar; 1(6115):789. PubMed ID: 630363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.